[Sheng Ta] February 2026 Monthly Revenue NT$466 Million (YoY -16.4%)
Sheng Ta (1720) released its financial report, showing that its February 2026 monthly revenue was NT$466 million, a 16.4% decrease compared to the same period last year. As a pharmaceutical company in the biotechnology and healthcare industry, its revenue performance may be affected by drug shipment schedules and market demand.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:18 (16h 18m after Collected)
Company Code: 1720
Company Name: Sheng Ta
Industry: Biotechnology and Healthcare
Data Month/Year: 2026-02
Current Month Revenue: 466,104 thousand NTD (NT$466 million)
Year-over-year Change from Same Month Last Year: -16.4%
Company Name: Sheng Ta
Industry: Biotechnology and Healthcare
Data Month/Year: 2026-02
Current Month Revenue: 466,104 thousand NTD (NT$466 million)
Year-over-year Change from Same Month Last Year: -16.4%